INFI - Infinity Pharmaceuticals Inc. (INFI) CEO Adelene Perkins on Q4 2021 Results - Earnings Call Transcript
Infinity Pharmaceuticals, Inc. (INFI) Q4 2021 Earnings Conference Call March 29, 2022 4:30 PM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - Chairman & CEO Robert Ilaria, Jr - Chief Medical Officer Larry Bloch - President & Treasurer Conference Call Participants Anupam Rama - JPMorgan Ted Tenthoff - Piper Sandler Kevin DeGeeter - Oppenheimer Soumit Roy - Jones Research Kalpit Patel - B. Riley Securities Robyn Karnauskas - Truist Securities Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals Conference Call to discuss the company's Operations and Full Year 2021 Financial Results. My name is Crystal, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. There will be a question and answer session for follow. Please be advised that this conference is being recorded at Infinity's request. Now I would like
For further details see:
Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q4 2021 Results - Earnings Call Transcript